Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions.

Rassy, Elie; Le Roy, Florence; Smolenschi, Cristina; Valéry, Marine; Boige, Valérie; Ducreux, Michel; Boilève, Alice

Rassy, Elie; Le Roy, Florence; Smolenschi, Cristina; Valéry, Marine; Boige, Valérie; Ducreux, Michel; Boilève, Alice.

Affiliation

Rassy E; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Le Roy F; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Smolenschi C; Service de Gastroentérologie, Groupe Hospitalier Bretagne Sud, Hôpital du Scorff, Lorient, France.
Valéry M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Boige V; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Ducreux M; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.
Boilève A; Département de Médecine Oncologique, Gustave Roussy, Villejuif, France.

JAMA Oncol ; 9(3): 434-435, 2023 03 01.

Article in En | MEDLINE | ID: mdl-36701137

This cohort study assesses the outcome of oxaliplatin desensitization for patients with gastrointestinal cancers who experienced hypersensitivity reactions after oxaliplatin infusion.

Subject(s)

Antineoplastic Agents; Colorectal Neoplasms; Humans; Oxaliplatin/adverse effects; Antineoplastic Agents/adverse effects; Colorectal Neoplasms/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Antineoplastic Agents Type of study: Observational_studies Limits: Humans Language: En Journal: JAMA Oncol Year: 2023 Document type: Article

Fulltext

XML

PubMed Links

Search on Google